Welcome, Guest. Please login or register.
March 04, 2021, 12:33:22 am

Login with username, password and session length

 

Members
Stats
  • Total Posts: 303
  • Total Topics: 159
  • Online Today: 9
  • Online Ever: 518
  • (January 21, 2020, 05:24:49 pm)
Users Online
Users: 0
Guests: 11
Total: 11

Welcome!

Welcome to the Cancer Health Forums, a round-the-clock discussion area for people who have any type of cancer, their friends and family and others with questions about living with cancer. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Cancer Health Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Matching Genetic Mutations to Targeted Therapy Improves Survival  (Read 1865 times)

Offline Cancer Health Editors

  • Jr. Member
  • **
  • Posts: 56
    • View Profile
Testing the genetic characteristics of tumors and using the results to guide the choice of treatment led to longer survival in a large study of people with hard-to-treat cancer, according to a presentation at the American Society of Clinical Oncology (ASCO) annual meeting last week in Chicago. However, the 10-year overall survival rate in the matched treatment group reached only 6 percent, showing much room for improvement.

“Precision medicine requires complete understanding of tumor biology,” lead researcher Apostolia Maria Tsimberidou, MD, PhD, of the University of Texas MD Anderson Cancer Center in Houston told reporters at an ASCO press briefing. “I’m optimistic that in the next few years we will dramatically improve outcomes of patients with cancer with the increasing use of precision medicine.”

Read more...
https://www.cancerhealth.com/article/matching-genetic-mutations-targeted-therapy-leads-improved-survival

 


© 2021 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.